Sandoz Group AG
SDZ
株式のランク
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
株価
$95.99
時価総額
$41.53B
変化（1日）
0.79%
変化（1年）
58.61%
国
CH
取引 Sandoz Group AG (SDZ)
カテゴリー
Healthcare
Sandoz Group AG（SDZ）の配当利回りの履歴
Sandoz Group AG（銘柄コード: SDZ）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.44%
過去5年間の平均配当利回り: 0.44%
Sandoz Group AG（SDZ）の2020から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2025 | 1.00% | -18.03% |
| 2024 | 1.22% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 3.18% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
